Foppa Luciana, Alessi Janine, Nemetz Betina, de Matos Rosimeri, Telo Gabriela Heiden, Schaan Beatriz D
Hospital de Clínicas de Porto Alegre (HCPA), Rua Ramiro Barcelos 2350, Porto Alegre, RS, 90035-003, Brazil.
Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos 2400, 2º andar, Porto Alegre, RS, 90035-003, Brazil.
Diabetol Metab Syndr. 2022 May 21;14(1):75. doi: 10.1186/s13098-022-00845-6.
Optimal glycemic control is the main goal for patients with diabetes. The results of type 1 diabetes patients' neglected demands during the pandemic can determine a long-term negative clinical, social, and economic impact, and result in worse diabetes control and a higher incidence of chronic complications. Therefore, this study aims to evaluate the impact of the COVID-19 outbreak in the quality of care of patients with type 1 diabetes in Southern Brazil.
Cohort study based on electronic medical records of patients with type 1 diabetes, with scheduled appointments between January 1st 2020, and November 6th 2020, at a university public hospital. The quality indicators used were: assessment of albuminuria and/or serum creatinine, lipid profile, thyroid-stimulating hormone, glycated hemoglobin, retinopathy, and neuropathy. McNemar test was used to analyze categorical variables and the Wilcoxon test for continuous variables.
Out of 289 patients, 49.5% were women aged 40 ± 12 years old. During the pandemic, 252 patients had at least one face-to-face appointment canceled. The quality of care indicators showed a significant worsening during the COVID-19 pandemic compared to the previous year (p < 0.001). In 2019, 23.2% of the participants had all the indicators evaluated, while in 2020, during the pandemic, only 3.5% had all of them evaluated.
The COVID-19 pandemic hindered the offer of comprehensive and quality care to patients with type 1 diabetes.
最佳血糖控制是糖尿病患者的主要目标。1型糖尿病患者在疫情期间被忽视的需求所产生的结果可能会决定长期的负面临床、社会和经济影响，并导致糖尿病控制恶化和慢性并发症发病率升高。因此，本研究旨在评估新冠疫情对巴西南部1型糖尿病患者护理质量的影响。
基于1型糖尿病患者电子病历的队列研究，研究对象为2020年1月1日至2020年11月6日期间在一所大学公立医院预约就诊的患者。所使用的质量指标包括：蛋白尿和/或血清肌酐评估、血脂谱、促甲状腺激素、糖化血红蛋白、视网膜病变和神经病变。采用 McNemar 检验分析分类变量，采用 Wilcoxon 检验分析连续变量。
289例患者中，49.5%为40±12岁的女性。在疫情期间，252例患者至少有一次面对面预约被取消。与上一年相比，新冠疫情期间护理质量指标显著恶化（p<0.001）。2019年，23.2%的参与者所有指标都得到了评估，而在2020年疫情期间，只有3.5%的参与者所有指标都得到了评估。
新冠疫情阻碍了为1型糖尿病患者提供全面优质的护理。
